Literature DB >> 29113248

Gene expression profile comparison between colorectal cancer and adjacent normal tissues.

Qian Yang1, Maohui Feng2, Xiang Ma2, Huachi Li2, Wei Xie2.   

Abstract

The present study aimed to compare gene expression profiles between colorectal cancer and adjacent normal tissues, and to perform a preliminarily analysis of the key genes and underlying molecular mechanisms implicated in colorectal cancer development. Gene expression microarray chips were used to screen genes that were differently expressed between colorectal cancer and adjacent normal tissues. Approximately 1,183 genes were differentially expressed in cancer tissues compared with adjacent normal tissues (P≤0.05; fold difference, >2.0), of which 570 genes were upregulated and 613 genes were downregulated. In total, 6 upregulated genes, including keratin 23, collagen type X α1, collagen type XI α1, cell migration-inducing hyaluronan-binding protein, transforming growth factor-β1 and V-Myc avian myelocytomatosis viral oncogene homolog, and 2 downregulated genes, including channel α subunit 7 and EPH receptor A7, were selected and validated using reverse transcription-quantitative polymerase chain reaction, which exhibited results that were consistent with the microarray analysis. These 1,183 differentially expressed genes were further classified into 71 groups based on their functions using gene ontology and pathway analyses. Kyoto Encyclopedia of Genes and Genomes analysis of these upregulated or downregulated genes suggested that 23 signaling pathways were involved. The present study preliminarily screened for and identified key genes and signaling pathways that may be closely associated with colorectal cancer development. However, subsequent gene function studies are required to verify these findings.

Entities:  

Keywords:  colorectal cancer; complementary DNA; gene oncology analysis; microarray; pathway analysis

Year:  2017        PMID: 29113248      PMCID: PMC5661416          DOI: 10.3892/ol.2017.6915

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  43 in total

1.  Mutations in AXIN2 cause colorectal cancer with defective mismatch repair by activating beta-catenin/TCF signalling.

Authors:  W Liu; X Dong; M Mai; R S Seelan; K Taniguchi; K K Krishnadath; K C Halling; J M Cunningham; L A Boardman; C Qian; E Christensen; S S Schmidt; P C Roche; D I Smith; S N Thibodeau
Journal:  Nat Genet       Date:  2000-10       Impact factor: 38.330

2.  Open source clustering software.

Authors:  M J L de Hoon; S Imoto; J Nolan; S Miyano
Journal:  Bioinformatics       Date:  2004-02-10       Impact factor: 6.937

3.  Revealing the molecular mechanism of colorectal cancer by establishing LGALS3-related protein-protein interaction network and identifying signaling pathways.

Authors:  Lu Han; Zhixiong Wu; Qicheng Zhao
Journal:  Int J Mol Med       Date:  2014-01-08       Impact factor: 4.101

4.  DNA methylation biomarker candidates for early detection of colon cancer.

Authors:  Joo Mi Yi; Mashaal Dhir; Angela A Guzzetta; Christine A Iacobuzio-Donahue; Kyu Heo; Kwang Mo Yang; Hiromu Suzuki; Minoru Toyota; Hwan-Mook Kim; Nita Ahuja
Journal:  Tumour Biol       Date:  2012-01-12

5.  Identification of c-MYC as a target of the APC pathway.

Authors:  T C He; A B Sparks; C Rago; H Hermeking; L Zawel; L T da Costa; P J Morin; B Vogelstein; K W Kinzler
Journal:  Science       Date:  1998-09-04       Impact factor: 47.728

6.  Evidence that depletion of the sorting nexin 1 by siRNA promotes HGF-induced MET endocytosis and MET phosphorylation in a gefitinib-resistant human lung cancer cell line.

Authors:  Yukio Nishimura; Soichi Takiguchi; Shigeru Ito; Kazuyuki Itoh
Journal:  Int J Oncol       Date:  2013-11-28       Impact factor: 5.650

Review 7.  Wnt pathway in osteosarcoma, from oncogenic to therapeutic.

Authors:  Yu Cai; Tiange Cai; Yan Chen
Journal:  J Cell Biochem       Date:  2014-04       Impact factor: 4.429

8.  Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.

Authors:  Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray
Journal:  Int J Cancer       Date:  2014-10-09       Impact factor: 7.396

9.  LEF-1 and TCF4 expression correlate inversely with survival in colorectal cancer.

Authors:  Lydia Kriegl; David Horst; Jana A Reiche; Jutta Engel; Thomas Kirchner; Andreas Jung
Journal:  J Transl Med       Date:  2010-11-22       Impact factor: 5.531

10.  Components of the canonical and non-canonical Wnt pathways are not mis-expressed in pituitary tumors.

Authors:  Leandro Machado Colli; Fabiano Saggioro; Luciano Neder Serafini; Renata Costa Camargo; Helio Rubens Machado; Ayrton Custodio Moreira; Sonir R Antonini; Margaret de Castro
Journal:  PLoS One       Date:  2013-04-26       Impact factor: 3.240

View more
  5 in total

1.  Expression of Stanniocalcin 2 in Breast Cancer and Its Clinical Significance.

Authors:  Shu-Ting Jiang; Hua-Qiao Wang; Tie-Cheng Yang; Dan-Wen Wang; Li-Jie Yang; Yi-Qing Xi; Fan-Zheng Kong; Xue-Kai Pan; Li-Hua Xu; Mao-Hui Feng; Wei Xie; Fei Su
Journal:  Curr Med Sci       Date:  2019-12-16

2.  Upregulation of STC2 in colorectal cancer and its clinicopathological significance.

Authors:  Chunxiao Zhang; Shuangqian Chen; Xiang Ma; Qian Yang; Fei Su; Xiang Shu; Wei Xie; Maohui Feng; Bin Xiong
Journal:  Onco Targets Ther       Date:  2019-02-15       Impact factor: 4.147

3.  Associations between matrix metalloproteinase, tissue inhibitor of metalloproteinase and collagen expression levels in the adjacent rectal tissue of colorectal carcinoma patients.

Authors:  Katarina Dibdiakova; Adam Svec; Zuzana Majercikova; Marek Adamik; Marian Grendar; Juraj Vana; Alexander Ferko; Jozef Hatok
Journal:  Mol Clin Oncol       Date:  2021-12-21

Review 4.  Modern Approaches to Testing Drug Sensitivity of Patients' Tumors (Review).

Authors:  I N Druzhkova; M V Shirmanova; D S Kuznetsova; М М Lukina; Е V Zagaynova
Journal:  Sovrem Tekhnologii Med       Date:  2020-08-27

5.  Does Elevated Pre-Treatment Plasma PD-L1 Level Indicate an Increased Tumor Burden and Worse Prognosis in Metastatic Colorectal Cancer?

Authors:  Magdolna Dank; Dorottya Mühl; Magdolna Herold; Lilla Hornyák; Attila Marcell Szasz; Zoltan Herold
Journal:  J Clin Med       Date:  2022-08-17       Impact factor: 4.964

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.